Astec Lifesciences has commenced commercial production at its new state of the art manufacturing facility. The said facility is located at company's new site in MIDC at Mahad. Pursuant to commencement of commercial production, the company expects this to contribute significantly to growth in terms of sales and profitability. Besides, the said facility incorporates proprietary process technology developed by its customer.
The above facility is in line with the MOU entered by the company with a multinational agrochemical major for a long term mutually exclusive confidential contract to supply an herbicide.
Further, with a view to set up additional manufacturing facilities and for future expansions, the company had already acquired land admeasuring approximately 40,000 square meters (10 acres).
Astec LifeSciences is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: